Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2024-08-16

FDA Approved: GENOTROPIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for Genotropin (somatropin) from Pfizer, resulting in changes to the labeling. The notice reflects the labeling update f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GENOTROPIN (SOMATROPIN)

Snippet

SUPPL AP for GENOTROPIN (SOMATROPIN)